info icon

This is a non-core endpoint: only basic statistics are computed.

ILD medications: pirfenidone

ILD_PIRFENIDONE

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC L04AX05

1 out of 7 registries used, show all original rules.

261

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

261

diagram downward connector

Include endpoints None

261

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

254

diagram downward connector
ILD_PIRFENIDONE

Control definitions

Control exclude ILD_MEDICATIONS

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 254 67 187
Unadjusted prevalence (%) 0.06 0.03 0.10
Mean age at first event (years) 70.88 71.07 70.82

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: ILD_PIRFENIDONE – ILD medications: pirfenidone
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after ILD medications: pirfenidone

Endpoint not on priority list, no data to show.